DiscoverX KILR™ Cytotoxicity Assay
The KILR Cytotoxicity Assay is a simple, non-radioactive and dye-free method to specifically measure target cancer cell cytotoxicity…
The assay has several applications in immune-oncology drug development including measuring target cell death through antibody dependent cell-mediated cytotoxicity (ADCC), complement dependent cytotoxicity (CDC), antibody dependent cell phagocytosis (ADCP), cytotoxic t-cell lymphocyte mediated death (CTL), bi-specific antibody mediated T-cell redirection, chimeric antigen receptor t-cell (CAR-T) and antibody drug conjugates (ADCs). Eliminate radioactivity with the KILR cytotoxicity assay and clearly measure your target cell cytotoxicity.
Downloads
Learn More
Click here to find out more via email
Related content from this organisation
Related topics
Assays, Drug Discovery Processes, Drug Targets, Screening
Related organisations
DiscoverX Corporation
